Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience. Arch Ital Urol Androl [Internet]. 2017 Dec. 31 [cited 2026 May 31];89(4):272-6. Available from: https://www.pagepressjournals.org/aiua/article/view/aiua.2017.4.272